Kite Pharma (KITE) Reports Q2 Loss of $2.27/Share

Kite Pharma (NASDAQ: KITE) reported Q2 EPS of ($2.27), versus ($0.32) reported last year.

For earnings history and earnings-related data on Kite Pharma (KITE) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Optimum Communications gets NYSE non-compliance notice over stock price
• Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15